...Potential Entry?In my point of view, probably a chance to entry below USD18, cut lose if breakdown USD16.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−63.85 M USD
0.00 USD
20.46 M
About BioAge Labs, Inc.
Sector
Industry
CEO
Kristen Fortney
Website
Headquarters
Richmond
Founded
2015
FIGI
BBG00HBTB0M9
BioAge Labs, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapeutic products for metabolic diseases, such as obesity, by targeting the biology of human beings. It offers Azelaprag, a potential oral therapeutic for obesity, followed by several earlier-stage metabolic programs. The company was founded by Kristen Fortney and Eric Morgen on April 1, 2015 and is headquartered in Richmond, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of BIOA is 6.14 USD — it has increased by 18.76% in the past 24 hours. Watch BioAge Labs, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange BioAge Labs, Inc. stocks are traded under the ticker BIOA.
BIOA stock has risen by 31.76% compared to the previous week, the month change is a −67.70% fall, over the last year BioAge Labs, Inc. has showed a −72.71% decrease.
We've gathered analysts' opinions on BioAge Labs, Inc. future price: according to them, BIOA price has a max estimate of 7.00 USD and a min estimate of 5.00 USD. Watch BIOA chart and read a more detailed BioAge Labs, Inc. stock forecast: see what analysts think of BioAge Labs, Inc. and suggest that you do with its stocks.
BIOA reached its all-time high on Oct 22, 2024 with the price of 26.62 USD, and its all-time low was 4.23 USD and was reached on Dec 10, 2024. View more price dynamics on BIOA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
BIOA stock is 34.53% volatile and has beta coefficient of 1.28. Track BioAge Labs, Inc. stock price on the chart and check out the list of the most volatile stocks — is BioAge Labs, Inc. there?
Yes, you can track BioAge Labs, Inc. financials in yearly and quarterly reports right on TradingView.
BioAge Labs, Inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
BIOA earnings for the last quarter are −6.70 USD per share, whereas the estimation was −0.68 USD resulting in a −890.01% surprise. The estimated earnings for the next quarter are −0.71 USD per share. See more details about BioAge Labs, Inc. earnings.
BioAge Labs, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
BIOA net income for the last quarter is −23.41 M USD, while the quarter before that showed −13.58 M USD of net income which accounts for −72.35% change. Track more BioAge Labs, Inc. financial stats to get the full picture.
No, BIOA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BIOA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BioAge Labs, Inc. stock right from TradingView charts — choose your broker and connect to your account.